The mission of the EPMA
The EPMA was formed in 2009 to cover particular deficits in medical sciences and healthcare. The main objective of the EPMA is to promote the paradigm change from delayed reactive medical services to evidence- based Predictive, Preventive and Personalised Medicine (PPPM) as an integrated science and healthcare practice.
Abstract
The EPMA is presented in 52 countries worldwide promoting innovative medical fields integrated into the actually performed European Commission program “Horizon 2020”, which aims to effectively advocate excellence in biomedical and medical sciences, while creating international integration and collaboration between innovative medical fields.
The EPMA Journal is the main instrument for the PPPM promotion
EPMA Journal (IF=3.8) is a journal of predictive, preventive and personalised medicine (PPPM). As the official journal of the EPMA, it has created an international forum for the discussion and exchange of research and methods to facilitate the creation of new approaches and models in PPPM, with a focus on the benefits to patients while advancing healthcare as a whole. EPMA Journal occupies a unique niche in the scientific literature: the absolute majority of the articles (about 90%) currently indexed in PubMed and covering PPPM was published in EPMA Journal. To support the multidisciplinary concepts within PPPM, the EPMA Journal Editorial Board consists of researchers across a variety of fields, who are committed to the promotion of PPPM globally. Though many are based in the European Union, the geographical spread of the Editorial Board is global, with representatives in Switzerland, the United States of America, Canada, Australia, Japan, Israel, China, South Korea, Turkey, Russia, Ukraine and many other countries. There are several EBMs who are particularly prominent/highly cited. Even with predominantly European governance, the impact of the EPMA Journal has a global reach.
EPMA Journal was highlighted at the EPMA Summit at the European Parliament in 2013 as the publishing platform for innovative, evidence-based concepts for advancing healthcare in Europe and worldwide. Many relevant consortia and societies refer to the recommendations and guidelines published in the EPMA Journal.
The journal provides the contributors with the “hybrid publishing model” which means that the authors may freely decide between publishing without the fee by “subscription” or, alternatively, paying the publishing fee for utilising the “open access” option - both indexed in “PubMed”. This is currently the best model offered by the publishing houses worldwide.
